Variation occurring in group A streptococci during human infection; progressive loss of M substance correlated with increasing susceptibility to bacteriostasis
about
Genome-wide analysis of group a streptococci reveals a mutation that modulates global phenotype and disease specificity.Asymptomatic carriage of group A streptococcus is associated with elimination of capsule production.Rheumatic fever in the 21st century.Streptococcus pyogenes Sortase Mutants Are Highly Susceptible to Killing by Host Factors Due to Aberrant Envelope PhysiologyOccurrence of R antigen specific for Group A type 3 streptococci.Studies on the pathogenicity of group A streptococci. II. The antiphagocytic effects of the M protein and the capsular gelThe occurrence of two M antigens in certain group A streptococci related to type 14.Streptococcus pyogenes type 12 M protein gene regulation by upstream sequences.Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin AEpidemiology of group A streptococcal infections--their changing frequency and severity.Expression of M type 12 protein by a group A streptococcus exhibits phaselike variation: evidence for coregulation of colony opacity determinants and M proteinThe importance of the group a streptococcus capsule in the pathogenesis of human infections: a historical perspective.Natural variation in the promoter of the gene encoding the Mga regulator alters host-pathogen interactions in group a Streptococcus carrier strains.Penicillin for streptococcal pharyngitis: has anything changed?Some observations on the influence of the micro-environment on loss of M substance in strains of Streptococcus pyogenes.Bacteriophage control of antiphagocytic determinants in group A streptococci.Preparation and properties of type-specific M antigen isolated from a group A, type 1 hemolytic streptococcus.Studies on the bacteriophages of hemolytic streptococci. II. Antigens released from the streptococcal cell wall by a phage-associated lysin.Structure of the has operon promoter and regulation of hyaluronic acid capsule expression in group A Streptococcus.
P2860
Q25257695-4D06EB56-9FE8-4584-BF34-C93CB2209A7BQ34298421-AD706BC5-16F4-44BF-8217-EAF0A6E02D2CQ34340970-3ABBD7EA-674B-471D-823A-CF3DF53EBE83Q35814379-F24813BC-A98E-4637-992B-B2D6DA9E3046Q36263907-E8AE64F8-B5A2-4D48-AB37-DCC1E15A0C68Q36264299-5914F531-839D-4B61-A784-07DC74C94170Q36265303-95A3A5BF-594C-4F15-9D57-D23EAA019212Q36274895-750AB7E4-1321-48EB-A542-795E3BBD968FQ36357627-47953E72-2913-4E75-BD58-F93466271D04Q37000292-D8197F39-5830-4A7F-92BB-8EA9FBB06B7CQ37024048-D55B08E4-CF2F-4BB3-AB5A-23A5DE41D15FQ37150291-73F6F3C9-D871-4439-A765-9697033B2F18Q37264797-0E37B460-567B-45CE-B4BE-E58675C0641AQ40608662-5C9CBCFC-7016-48D8-B4FD-339DD6789734Q41822968-FDD0D66B-CC90-4215-9C41-418D6D46BD60Q41991832-3A03BE13-CDB7-4184-8609-BF3D673EDA3FQ42821108-32FEC1AA-489F-424C-B551-A18B9080944AQ42823062-6F9729FE-2CF0-49EF-ACB3-568AA7F0F53CQ47986806-4D0A4C8B-A4D4-41D2-AA94-0D52BDD3C30F
P2860
Variation occurring in group A streptococci during human infection; progressive loss of M substance correlated with increasing susceptibility to bacteriostasis
description
1948 nî lūn-bûn
@nan
1948年の論文
@ja
1948年論文
@yue
1948年論文
@zh-hant
1948年論文
@zh-hk
1948年論文
@zh-mo
1948年論文
@zh-tw
1948年论文
@wuu
1948年论文
@zh
1948年论文
@zh-cn
name
Variation occurring in group A ...... sceptibility to bacteriostasis
@en
Variation occurring in group A ...... sceptibility to bacteriostasis
@nl
type
label
Variation occurring in group A ...... sceptibility to bacteriostasis
@en
Variation occurring in group A ...... sceptibility to bacteriostasis
@nl
prefLabel
Variation occurring in group A ...... sceptibility to bacteriostasis
@en
Variation occurring in group A ...... sceptibility to bacteriostasis
@nl
P2860
P356
P1476
Variation occurring in group A ...... sceptibility to bacteriostasis
@en
P2093
P2860
P304
P356
10.1084/JEM.87.6.521
P407
P577
1948-06-01T00:00:00Z